Quantum-Si incorporated QSI
Set alert
At close
Pre-market · Nov 3, 8:45 AM ET
- YTD
- +14.55%
- 1 year
- -37.00%
- Open
- 1.49
- Prev close
- 1.46
- Mkt cap
- 275.79M
- Vol
- 8.19M
- Avg vol
- 6.22M
- EPS
- -0.45
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.23
- High
- 1.50
- Forward P/E
- -1.66
- Beta
- 2.93
- Short ratio
- 0.53
- Inst. own
- 36.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 7, 2024
- 50-d avg
- 1.08
- 200-d avg
- 1.26
- 1y target
- 3.25
MAX chart
Events in this range
- Dec 8, 2023Rating: HC Wainwright & Co. · — → Buy
- Feb 29, 2024Earnings: -0.16; estimate -0.16; surprise 0%
- Mar 1, 2024Rating: HC Wainwright & Co. · Buy → Buy
- May 9, 2024Earnings: -0.14; estimate -0.23; surprise 39.13%
- May 9, 2024Earnings: —; estimate -0.23; surprise —%
- May 10, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Aug 7, 2024Earnings: -0.16; estimate -0.21; surprise 23.81%
- Aug 7, 2024Earnings: —; estimate -0.21; surprise —%
- Nov 12, 2024Earnings: -0.18; estimate -0.21; surprise 14.29%
- Nov 13, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Nov 13, 2024Rating: Canaccord Genuity · Hold → Hold
- Nov 21, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (100)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 24, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| SMA: Bearish | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| MACD: Sell Signal | Nov 17, 2025 | 11 months ago |
| SMA: Bearish | Nov 3, 2025 | 1 year ago |
| SMA: Bearish | Nov 3, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 29, 2025 | 1 year ago |
| SMA: Bullish | Sep 15, 2025 | 1 year ago |
| SMA: Bullish | Sep 15, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
Newest 20 of 100.
Key statistics
- Market cap
- 204.31M
- Enterprise value
- 3.01M
- Trailing P/E
- 0.00
- Forward P/E
- -1.66
- PEG ratio
- 0.00
- Price / sales
- 90.16
- Price / book
- 0.89
- EPS (TTM)
- -0.64
- Beta
- 2.93
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 2.27M
- Revenue growth
- 252.90%
- Free cash flow
- 0
- Total cash
- 196.34M
- Total debt
- 13.82M
- Return on equity
- -35.79%
- Shares outstanding
- 155.96M
- Short % of float
- 10.52%
- 50-day average
- 1.08
- 200-day average
- 1.26
Analyst view
Consensus: none
- Target (low)
- 1.00
- Target (mean)
- 3.25
- Target (high)
- 5.50
- Strong buy1
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Aug 7, 2024
Expected Aug 7, 2024. Consensus EPS estimate -0.19.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | -0.21 | -0.18 | +0.03 | +14.29% |
| Aug 7, 2024 | Jun 1, 2024 | -0.21 | -0.16 | +0.05 | +23.81% |
| Aug 7, 2024 | Jun 1, 2024 | -0.21 | — | — | — |
| May 9, 2024 | Mar 1, 2024 | -0.23 | -0.14 | +0.09 | +39.13% |
| May 9, 2024 | Mar 1, 2024 | -0.23 | — | — | — |
| Feb 29, 2024 | Dec 1, 2023 | -0.16 | -0.16 | 0.00 | 0.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 21, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Nov 13, 2024 | Canaccord Genuity | main | Hold | Hold |
| Nov 13, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| May 10, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Mar 1, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Dec 8, 2023 | HC Wainwright & Co. | init | — | Buy |
About Quantum-Si incorporated
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; Proteus, transforming proteomic research; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company has a collaboration with SkyWaterTechnology for the development of consumable for Proteus, that will enable simultaneous protein sequencing. Quantum-Si incorporated was founded in 2013 is headquartered in Branford, Connecticut.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- quantum-si.com
News
- Head-To-Head Comparison: Quantum-Si (NASDAQ:QSI) vs. Quanterix (NASDAQ:QTRX)
- Quantum-Si Stock Booms: What's Going On?
- 12 Health Care Stocks Moving In Friday's Intraday Session
- Quantum-Si Demonstrates Detection of 19 Amino Acids in Proteus Development Program; Co Is Now Working To Deploy That Capability Into A Developmental Sequencing Kit For Routine Use On Integrated Proteus Instruments
- Top 3 Health Care Stocks That May Collapse In Q4
- Align Technology, Group 1 Automotive And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
- Nike Posts Mixed Q1 Results, Joins Mangoceuticals And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
- Why Synaptics Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
Your note
Sign in to keep a note on QSI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BENNETT TODD C | Officer | Stock Award(Grant) | Sep 16, 2024 | 510,152 |
| DOWDY PAULA | Director | Stock Award(Grant) | Mar 21, 2024 | 159,217 |
| HAWKINS JEFFREY ALAN | Chief Executive Officer | Purchase | Aug 8, 2024 | 1,003,760 |
| JAFRI AMIR | Director | Stock Award(Grant) | Sep 24, 2023 | 115,942 |
| JOHNSTON GRACE | Officer | Sale | Jun 23, 2024 | 295,940 |
| KENNY JOHN P | Director | Stock Award(Grant) | May 21, 2023 | 114,285 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ARK Investment Management, LLC | 9.65% | 11,842,609 | 15.51M | Sep 29, 2024 |
| Sumitomo Mitsui Trust Holdings, Inc. | 6.15% | 7,547,912 | 9.89M | Sep 29, 2024 |
| Nikko Asset Management Americas, Inc. | 6.13% | 7,527,912 | 9.86M | Sep 29, 2024 |
| Blackrock Inc. | 5.62% | 6,900,127 | 9.04M | Sep 29, 2024 |
| Vanguard Group Inc | 4.10% | 5,037,258 | 6.60M | Sep 29, 2024 |
| Geode Capital Management, LLC | 1.89% | 2,316,921 | 3.04M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ARK ETF Tr-ARK Genomic Revolution ETF | 9.36% | 11,497,793 | 15.06M | Oct 30, 2024 |
| Vanguard Total Stock Market Index Fund | 2.46% | 3,017,586 | 3.95M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.99% | 2,441,722 | 3.20M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 1.04% | 1,276,774 | 1.67M | Sep 29, 2024 |
| Fidelity Small Cap Index Fund | 0.84% | 1,027,584 | 1.35M | Aug 30, 2024 |
| iShares Russell 2000 Value ETF | 0.83% | 1,023,701 | 1.34M | Oct 30, 2024 |
